Hitoshi Matsuda
Directeur/Membre du Conseil chez GNI Hong Kong Ltd.
Profil
Hitoshi Matsuda currently works at GNI-EPS Pharmaceuticals, inc., as Director from 2013, GNI Hong Kong Ltd., as Director from 2013, and Shanghai Genomics, Inc., as Auditor from 2013.
Mr. Matsuda also formerly worked at GNI Group Ltd., as Chief Operating Officer & Director and Continent Pharmaceutical Inc., as Director.
Mr. Matsuda received his graduate degree from Keio University.
Postes actifs de Hitoshi Matsuda
| Sociétés | Poste | Début |
|---|---|---|
Shanghai Genomics, Inc.
 Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu. | Comptroller/Controller/Auditor | 01/07/2013 |
| GNI-EPS Pharmaceuticals, inc. | Directeur/Membre du Conseil | 01/07/2013 |
GNI Hong Kong Ltd.
 GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services GNI Hong Kong Ltd. engages in property management. The company was founded on July 31, 2013 and is headquartered in Hong Kong. | Directeur/Membre du Conseil | 01/07/2013 |
Anciens postes connus de Hitoshi Matsuda
| Sociétés | Poste | Fin |
|---|---|---|
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | - |
| GNI GROUP LTD. | Directeur des opérations | - |
Formation de Hitoshi Matsuda
| Keio University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GNI GROUP LTD. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Shanghai Genomics, Inc.
Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu. | Health Technology |
| GNI-EPS Pharmaceuticals, inc. | |
GNI Hong Kong Ltd.
GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services GNI Hong Kong Ltd. engages in property management. The company was founded on July 31, 2013 and is headquartered in Hong Kong. | Commercial Services |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Health Technology |
